A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventable

Matthias Briel1, Kelechi Kalu Olu2, Erik von Elm3

  • 1Department of Clinical Research, Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Spitalstrasse 12, 4031 Basel, Switzerland; Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S 4K1, Canada.

Abstract

Insights

Many randomized controlled trials (RCTs) fail due to poor participant recruitment. Overestimating eligible participants and negative views on interventions were common reasons, highlighting the need for better planning and pilot studies.

Area of Science:

  • Clinical Trials
  • Research Methodology

Background:

  • Recruitment failure is a significant cause for the discontinuation of randomized controlled trials (RCTs).
  • Understanding the reasons behind recruitment failure is crucial for improving future trial design and success rates.

Purpose of the Study:

  • To systematically collect and categorize reported reasons for recruitment failure in discontinued RCTs.
  • To evaluate the quality of reporting regarding recruitment challenges in published RCTs.

Main Methods:

  • A systematic literature search was conducted on MEDLINE and EMBASE databases for RCTs discontinued due to poor recruitment between 2010 and 2014.
  • Information was extracted by two independent investigators using standardized forms, and reasons for recruitment failure were classified through an iterative approach.

Main Results:

  • Out of 172 included RCTs, 131 (76%) reported reasons for discontinuation due to recruitment failure.
  • Twenty-eight distinct reasons were identified, with the most frequent being overestimation of eligible participant prevalence and negative perceptions of trial interventions.
  • Reporting on key recruitment process details, such as participant identification and screening numbers, was often inadequate.

Conclusions:

  • The developed classification system can serve as a checklist to aid investigators in planning RCTs.
  • Many recruitment failures appear preventable, suggesting the utility of pilot studies incorporating planned informed consent procedures.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.6K
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.8K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
686